Search - tctmd.com

Displaying 41 - 55 of 55

Sort: Relevancy | Date

News Conference News ESC 2016

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Michael O'Riordan

August 28, 2016

News Conference News ESC 2015

PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care

L.A. McKeown

September 02, 2015

News Conference News ESC 2014

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

Caitlin E. Cox

September 03, 2014

News Conference News ESC 2014

PROTECT: ZES Sustain Lead Over SES at 5 Years

Caitlin E. Cox

September 03, 2014

News Conference News ESC 2014

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Todd Neale

September 01, 2014

News Conference News ESC 2013

Usefulness of IABP Questioned in MI Patients with Cardiogenic Shock

Yael L. Maxwell

September 03, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

News Conference News ESC 2012

FAME 2: PCI Bests Medical Therapy in Stable Patients with Proven Ischemia

August 28, 2012

Presentation ESC 2012

Randomized Comparison of Intra-aortic Balloon Counterpulsation vs. Optimal Medical Therapy in Addition to Early Revasacularization in AMI and Cardiogenic Shock

Presenter: 168042|Holger Thiele

August 27, 2012

News Conference News ESC 2012

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

August 27, 2012

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Conference News

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

September 01, 2011

Advertisement

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

PROTECT: ZES Sustain Lead Over SES at 5 Years

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Usefulness of IABP Questioned in MI Patients with Cardiogenic Shock

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

FAME 2: PCI Bests Medical Therapy in Stable Patients with Proven Ischemia

Randomized Comparison of Intra-aortic Balloon Counterpulsation vs. Optimal Medical Therapy in Addition to Early Revasacularization in AMI and Cardiogenic Shock

No Benefit of Intra-aortic Balloon Pump in MI Patients with Shock

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content